Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plans and Stock-Based Compensation (Tables)

v3.21.1
Equity Incentive Plans and Stock-Based Compensation (Tables)
3 Months Ended
Apr. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Option Activity Under Stock Plans

The following table summarizes the option activity under our stock plans during the reporting period:

 

 

 

Number of Stock

Options

(in thousands)

 

 

Weighted-

Average Exercise

Price

 

 

Weighted-Average

Remaining

Contractual

Life (years)

 

 

Aggregate

Intrinsic Value

(in thousands)

 

Outstanding as of January 31, 2021

 

 

23,013

 

 

$

1.58

 

 

 

7.9

 

 

$

1,207,831

 

Granted

 

 

147

 

 

$

0.10

 

 

 

 

 

 

 

 

 

Exercised

 

 

(1,881

)

 

$

1.26

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(172

)

 

$

2.32

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

$

 

 

 

 

 

 

 

 

 

Outstanding as of April 30, 2021

 

 

21,107

 

 

$

1.59

 

 

 

7.5

 

 

$

1,486,032

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and exercisable as of

   April 30, 2021

 

 

9,925

 

 

$

1.04

 

 

 

6.6

 

 

$

704,260

 

Summary of RSU Activity

RSU activity during the three months ended April 30, 2021 consisted of the following (in thousands except per share amounts):

 

 

 

RSUs (in thousands)

 

 

Weighted-Average Grant

Date Fair Value Per Share

 

Unvested as of January 31, 2021

 

 

34,753

 

 

$

10.80

 

Granted

 

 

2,818

 

 

$

56.00

 

Vested (1)

 

 

(17,921

)

 

$

6.40

 

Forfeited

 

 

(513

)

 

$

12.45

 

Unvested as of April 30, 2021

 

 

19,137

 

 

$

21.53

 

(1) Class A common stock has not been issued in connection with 17,532 vested RSUs because such RSUs were unsettled as of April 30, 2021.

 

Summary of Stock-Based Compensation Expense in Condensed Consolidated Statements of Operations

We classified stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):

 

 

 

Three Months Ended April 30,

 

 

 

2021

 

 

2020

 

Cost of revenue

 

$

25,145

 

 

$

383

 

Sales and marketing

 

 

119,293

 

 

 

1,853

 

Research and development

 

 

65,616

 

 

 

1,816

 

General and administrative

 

 

40,781

 

 

 

4,149

 

Total

 

$

250,835

 

 

$

8,201